Goldman Sachs’s CNS Pharmaceuticals CNSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-67
Closed -$4.86K 5104
2024
Q4
$4.86K Buy
67
+20
+43% +$1.45K ﹤0.01% 4964
2024
Q3
$3.68K Buy
+47
New +$3.68K ﹤0.01% 4775
2022
Q4
Hold
0
-$3K 5174
2022
Q3
Hold
0
5366
2021
Q2
Hold
0
-$28K 5377
2021
Q1
Hold
0
5184